Variation in Ligand Responses of the Bitter Taste Receptors TAS2R1 And
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Information for Instructor
Using a Single-Nucleotide Polymorphism to Predict Bitter-Tasting Ability 21 INFORMATION FOR INSTRUCTOR CONCEPTS AND METHODS This laboratory can help students understand several important concepts of modern biology: • The relationship between genotype and phenotype. • The use of single-nucleotide polymorphisms (SNPs) in predicting drug response (pharmacogenetics). • A number of SNPs are inherited together as a haplotype. • The movement between in vitro experimentation and in silico computation. The laboratory uses several methods for modern biological research: • DNA extraction and purification. • Polymerase chain reaction (PCR). • DNA restriction. • Gel electrophoresis. • Bioinformatics. LAB SAFETY The National Association of Biology Teachers recognizes the importance of laboratory activities using human body samples and has developed safety guidelines to minimize the risk of transmitting serious disease. ("The Use of Human Body Fluids and Tissue Products in Biology," News & Views, June 1996.) These are summarized below: • Collect samples only from students under your direct supervision. • Do not use samples brought from home or obtained from an unknown source. • Do not collect samples from students who are obviously ill or are known to have a serious communicable disease. • Have students wear proper safety apparel: latex or plastic gloves, safety glasses or goggles, and lab coat or apron. • Supernatants and samples may be disposed of in public sewers (down lab drains). • Have students wash their hands at the end of the lab period. • Do not store samples in a refrigerator or freezer used for food. The risk of spreading an infectious agent by this lab method is much less likely than from natural atomizing processes, such as coughing or sneezing. -
A Computational Approach for Defining a Signature of Β-Cell Golgi Stress in Diabetes Mellitus
Page 1 of 781 Diabetes A Computational Approach for Defining a Signature of β-Cell Golgi Stress in Diabetes Mellitus Robert N. Bone1,6,7, Olufunmilola Oyebamiji2, Sayali Talware2, Sharmila Selvaraj2, Preethi Krishnan3,6, Farooq Syed1,6,7, Huanmei Wu2, Carmella Evans-Molina 1,3,4,5,6,7,8* Departments of 1Pediatrics, 3Medicine, 4Anatomy, Cell Biology & Physiology, 5Biochemistry & Molecular Biology, the 6Center for Diabetes & Metabolic Diseases, and the 7Herman B. Wells Center for Pediatric Research, Indiana University School of Medicine, Indianapolis, IN 46202; 2Department of BioHealth Informatics, Indiana University-Purdue University Indianapolis, Indianapolis, IN, 46202; 8Roudebush VA Medical Center, Indianapolis, IN 46202. *Corresponding Author(s): Carmella Evans-Molina, MD, PhD ([email protected]) Indiana University School of Medicine, 635 Barnhill Drive, MS 2031A, Indianapolis, IN 46202, Telephone: (317) 274-4145, Fax (317) 274-4107 Running Title: Golgi Stress Response in Diabetes Word Count: 4358 Number of Figures: 6 Keywords: Golgi apparatus stress, Islets, β cell, Type 1 diabetes, Type 2 diabetes 1 Diabetes Publish Ahead of Print, published online August 20, 2020 Diabetes Page 2 of 781 ABSTRACT The Golgi apparatus (GA) is an important site of insulin processing and granule maturation, but whether GA organelle dysfunction and GA stress are present in the diabetic β-cell has not been tested. We utilized an informatics-based approach to develop a transcriptional signature of β-cell GA stress using existing RNA sequencing and microarray datasets generated using human islets from donors with diabetes and islets where type 1(T1D) and type 2 diabetes (T2D) had been modeled ex vivo. To narrow our results to GA-specific genes, we applied a filter set of 1,030 genes accepted as GA associated. -
Supplementary Table 3 Complete List of RNA-Sequencing Analysis of Gene Expression Changed by ≥ Tenfold Between Xenograft and Cells Cultured in 10%O2
Supplementary Table 3 Complete list of RNA-Sequencing analysis of gene expression changed by ≥ tenfold between xenograft and cells cultured in 10%O2 Expr Log2 Ratio Symbol Entrez Gene Name (culture/xenograft) -7.182 PGM5 phosphoglucomutase 5 -6.883 GPBAR1 G protein-coupled bile acid receptor 1 -6.683 CPVL carboxypeptidase, vitellogenic like -6.398 MTMR9LP myotubularin related protein 9-like, pseudogene -6.131 SCN7A sodium voltage-gated channel alpha subunit 7 -6.115 POPDC2 popeye domain containing 2 -6.014 LGI1 leucine rich glioma inactivated 1 -5.86 SCN1A sodium voltage-gated channel alpha subunit 1 -5.713 C6 complement C6 -5.365 ANGPTL1 angiopoietin like 1 -5.327 TNN tenascin N -5.228 DHRS2 dehydrogenase/reductase 2 leucine rich repeat and fibronectin type III domain -5.115 LRFN2 containing 2 -5.076 FOXO6 forkhead box O6 -5.035 ETNPPL ethanolamine-phosphate phospho-lyase -4.993 MYO15A myosin XVA -4.972 IGF1 insulin like growth factor 1 -4.956 DLG2 discs large MAGUK scaffold protein 2 -4.86 SCML4 sex comb on midleg like 4 (Drosophila) Src homology 2 domain containing transforming -4.816 SHD protein D -4.764 PLP1 proteolipid protein 1 -4.764 TSPAN32 tetraspanin 32 -4.713 N4BP3 NEDD4 binding protein 3 -4.705 MYOC myocilin -4.646 CLEC3B C-type lectin domain family 3 member B -4.646 C7 complement C7 -4.62 TGM2 transglutaminase 2 -4.562 COL9A1 collagen type IX alpha 1 chain -4.55 SOSTDC1 sclerostin domain containing 1 -4.55 OGN osteoglycin -4.505 DAPL1 death associated protein like 1 -4.491 C10orf105 chromosome 10 open reading frame 105 -4.491 -
Download Download
Supplementary Figure S1. Results of flow cytometry analysis, performed to estimate CD34 positivity, after immunomagnetic separation in two different experiments. As monoclonal antibody for labeling the sample, the fluorescein isothiocyanate (FITC)- conjugated mouse anti-human CD34 MoAb (Mylteni) was used. Briefly, cell samples were incubated in the presence of the indicated MoAbs, at the proper dilution, in PBS containing 5% FCS and 1% Fc receptor (FcR) blocking reagent (Miltenyi) for 30 min at 4 C. Cells were then washed twice, resuspended with PBS and analyzed by a Coulter Epics XL (Coulter Electronics Inc., Hialeah, FL, USA) flow cytometer. only use Non-commercial 1 Supplementary Table S1. Complete list of the datasets used in this study and their sources. GEO Total samples Geo selected GEO accession of used Platform Reference series in series samples samples GSM142565 GSM142566 GSM142567 GSM142568 GSE6146 HG-U133A 14 8 - GSM142569 GSM142571 GSM142572 GSM142574 GSM51391 GSM51392 GSE2666 HG-U133A 36 4 1 GSM51393 GSM51394 only GSM321583 GSE12803 HG-U133A 20 3 GSM321584 2 GSM321585 use Promyelocytes_1 Promyelocytes_2 Promyelocytes_3 Promyelocytes_4 HG-U133A 8 8 3 GSE64282 Promyelocytes_5 Promyelocytes_6 Promyelocytes_7 Promyelocytes_8 Non-commercial 2 Supplementary Table S2. Chromosomal regions up-regulated in CD34+ samples as identified by the LAP procedure with the two-class statistics coded in the PREDA R package and an FDR threshold of 0.5. Functional enrichment analysis has been performed using DAVID (http://david.abcc.ncifcrf.gov/) -
Bitter Taste Perception in Neanderthals Through the Analysis of The
View metadata, citation and similar papers Downloadedat core.ac.uk from http://rsbl.royalsocietypublishing.org/ on March 22, 2016 brought to you by CORE provided by Repositorio Institucional de la Universidad de Oviedo Biol. Lett. (2009) 5, 809–811 The most extensively studied taste variation in doi:10.1098/rsbl.2009.0532 humans is sensitivity to a bitter substance called phe- Published online 12 August 2009 nylthiocarbamide (PTC). Although approximately 75 Evolutionary biology per cent of the world population perceives this sub- stance as intensely bitter, it is virtually tasteless for the remaining 25 per cent of the population (Kim & Bitter taste perception in Drayna 2004). This is owing to a dominant ‘taster’ allele that shows a similar frequency to the recessive Neanderthals through the ‘non-taster’ allele. PTC itself is not found in any vegetable, but chemically similar substances that analysis of the TAS2R38 produce an identical response to PTC are present in gene many plant foods (including Brussels sprouts, cabbage, broccoli and others). It was discovered Carles Lalueza-Fox1,*, Elena Gigli1, (Kim et al. 2003) that most of the variation in PTC Marco de la Rasilla2, Javier Fortea2 sensitivity is related to polymorphisms at the and Antonio Rosas3 TAS2R38 gene, a single 1002 bp coding exon that encodes a 333-amino-acid, G-protein-coupled recep- 1Institut de Biologia Evolutiva, CSIC-UPF, Dr. Aiguader 88, 08003 Barcelona, Spain tor. The TAS2R38 gene has three amino-acid changes 2A´ rea de Prehistoria, Departamento de Historia, Universidad de Oviedo, in high frequencies that determine only five main hap- Teniente Alfonso Martı´nez s/n, 33011 Oviedo, Spain lotypes. -
(12) United States Patent (10) Patent No.: US 9,347,934 B2 Shekdar Et Al
USOO9347934B2 (12) United States Patent (10) Patent No.: US 9,347,934 B2 Shekdar et al. (45) Date of Patent: May 24, 2016 (54) ASSAYS FOR IDENTIFYING COMPOUNDS 2008, OO38739 A1 2/2008 Li et al. THAT MODULATE BITTERTASTE 2008/0167286 A1* 7/2008 Gopalakrishnan et al. ........................ 514,21016 (71) Applicants: CHROMOCELL CORPORATION, 2010/01298.33 A1* 5/2010 Brune et al. ................. 435/721 North Brunswick, NJ (US); KRAFT FOODS GROUP BRANDS LLC, FOREIGN PATENT DOCUMENTS Northfield, IL (US) CN 1341632 A 3, 2002 CN 101583717 A 11, 2009 (72) Inventors: Kambiz Shekdar, New York, NY (US); CN 101828.111 A 9, 2010 Purvi Manoj Shah, Bridgewater, NJ WO WO-0038536 A2 7, 2000 WO WO-2004O29087 4/2004 (US); Joseph Gunnet, Flemington, NJ WO WO-2006053771 A2 5, 2006 (US); Jane V. Leland, Wilmette, IL WO WO-2007002026 A2 1/2007 (US); Peter H. Brown, Glenview, IL WO WO-2008057470 5, 2008 (US); Louise Slade, Morris Plains, NJ WO WO-2008119.195 A1 10, 2008 (US) WO WO-20081191.96 10, 2008 WO WO-20081191.97 10, 2008 (73) Assignees: Chromocell Corporation, North W WSi. A2 1929 Brunswick, NJ (US); Kraft Foods WO WO-2010O886.33 8, 2010 Group Brands LLC, Northfield, IL WO WO-2010O99983 A1 9, 2010 (US) WO WO-2013022947 2, 2013 (*) Notice: Subject to any disclaimer, the term of this OTHER PUBLICATIONS patent is extended or adjusted under 35 U.S.C. 154(b) by 0 days. Bachmanov et al., Taste Receptor Genes, 2007, 27:389-414.* Behrens et al., Structural Requirements for Bitter Taste Receptor (21) Appl. -
G Protein-Coupled Receptors
S.P.H. Alexander et al. The Concise Guide to PHARMACOLOGY 2015/16: G protein-coupled receptors. British Journal of Pharmacology (2015) 172, 5744–5869 THE CONCISE GUIDE TO PHARMACOLOGY 2015/16: G protein-coupled receptors Stephen PH Alexander1, Anthony P Davenport2, Eamonn Kelly3, Neil Marrion3, John A Peters4, Helen E Benson5, Elena Faccenda5, Adam J Pawson5, Joanna L Sharman5, Christopher Southan5, Jamie A Davies5 and CGTP Collaborators 1School of Biomedical Sciences, University of Nottingham Medical School, Nottingham, NG7 2UH, UK, 2Clinical Pharmacology Unit, University of Cambridge, Cambridge, CB2 0QQ, UK, 3School of Physiology and Pharmacology, University of Bristol, Bristol, BS8 1TD, UK, 4Neuroscience Division, Medical Education Institute, Ninewells Hospital and Medical School, University of Dundee, Dundee, DD1 9SY, UK, 5Centre for Integrative Physiology, University of Edinburgh, Edinburgh, EH8 9XD, UK Abstract The Concise Guide to PHARMACOLOGY 2015/16 provides concise overviews of the key properties of over 1750 human drug targets with their pharmacology, plus links to an open access knowledgebase of drug targets and their ligands (www.guidetopharmacology.org), which provides more detailed views of target and ligand properties. The full contents can be found at http://onlinelibrary.wiley.com/doi/ 10.1111/bph.13348/full. G protein-coupled receptors are one of the eight major pharmacological targets into which the Guide is divided, with the others being: ligand-gated ion channels, voltage-gated ion channels, other ion channels, nuclear hormone receptors, catalytic receptors, enzymes and transporters. These are presented with nomenclature guidance and summary information on the best available pharmacological tools, alongside key references and suggestions for further reading. -
G Protein‐Coupled Receptors
S.P.H. Alexander et al. The Concise Guide to PHARMACOLOGY 2019/20: G protein-coupled receptors. British Journal of Pharmacology (2019) 176, S21–S141 THE CONCISE GUIDE TO PHARMACOLOGY 2019/20: G protein-coupled receptors Stephen PH Alexander1 , Arthur Christopoulos2 , Anthony P Davenport3 , Eamonn Kelly4, Alistair Mathie5 , John A Peters6 , Emma L Veale5 ,JaneFArmstrong7 , Elena Faccenda7 ,SimonDHarding7 ,AdamJPawson7 , Joanna L Sharman7 , Christopher Southan7 , Jamie A Davies7 and CGTP Collaborators 1School of Life Sciences, University of Nottingham Medical School, Nottingham, NG7 2UH, UK 2Monash Institute of Pharmaceutical Sciences and Department of Pharmacology, Monash University, Parkville, Victoria 3052, Australia 3Clinical Pharmacology Unit, University of Cambridge, Cambridge, CB2 0QQ, UK 4School of Physiology, Pharmacology and Neuroscience, University of Bristol, Bristol, BS8 1TD, UK 5Medway School of Pharmacy, The Universities of Greenwich and Kent at Medway, Anson Building, Central Avenue, Chatham Maritime, Chatham, Kent, ME4 4TB, UK 6Neuroscience Division, Medical Education Institute, Ninewells Hospital and Medical School, University of Dundee, Dundee, DD1 9SY, UK 7Centre for Discovery Brain Sciences, University of Edinburgh, Edinburgh, EH8 9XD, UK Abstract The Concise Guide to PHARMACOLOGY 2019/20 is the fourth in this series of biennial publications. The Concise Guide provides concise overviews of the key properties of nearly 1800 human drug targets with an emphasis on selective pharmacology (where available), plus links to the open access knowledgebase source of drug targets and their ligands (www.guidetopharmacology.org), which provides more detailed views of target and ligand properties. Although the Concise Guide represents approximately 400 pages, the material presented is substantially reduced compared to information and links presented on the website. -
Methods to Identify Tas2r Modulators Verfahren Zur Identifizierung Von Tas2r Modulatoren Procédé D’Identification De Modulateurs Tas2r
(19) TZZ _¥¥ _T (11) EP 2 137 322 B1 (12) EUROPEAN PATENT SPECIFICATION (45) Date of publication and mention (51) Int Cl.: of the grant of the patent: C12Q 1/68 (2006.01) A23L 2/52 (2006.01) 27.02.2013 Bulletin 2013/09 A23G 4/00 (2006.01) C07C 53/134 (2006.01) (21) Application number: 08714784.9 (86) International application number: PCT/CH2008/000134 (22) Date of filing: 27.03.2008 (87) International publication number: WO 2008/119195 (09.10.2008 Gazette 2008/41) (54) METHODS TO IDENTIFY TAS2R MODULATORS VERFAHREN ZUR IDENTIFIZIERUNG VON TAS2R MODULATOREN PROCÉDÉ D’IDENTIFICATION DE MODULATEURS TAS2R (84) Designated Contracting States: • BEHRENS MAIK ET AL: "Members of RTP and AT BE BG CH CY CZ DE DK EE ES FI FR GB GR REEP gene families influence functional bitter HR HU IE IS IT LI LT LU LV MC MT NL NO PL PT taste receptor expression" JOURNAL OF RO SE SI SK TR BIOLOGICAL CHEMISTRY, vol. 281, no. 29, July 2006(2006-07), pages 20650-20659, XP002494217 (30) Priority: 30.03.2007 US 909143 P ISSN: 0021-9258 30.07.2007 US 962549 P • KUHN CHRISTINA ET AL: "Bitter taste receptors for saccharin and acesulfame K" JOURNAL OF (43) Date of publication of application: NEUROSCIENCE, vol. 24, no. 45, 10 November 30.12.2009 Bulletin 2009/53 2004 (2004-11-10), pages 10260-10265, XP002494218 ISSN: 0270-6474 (73) Proprietor: Givaudan SA • BUFE BERND ET AL: "The human TAS2R16 1214 Vernier (CH) receptor mediates bitter taste in response to beta- glucopyranosides" NATURE GENETICS, (72) Inventors: NATURE PUBLISHING GROUP, NEW YORK, US, • BRUNE, Nicole, Erna, Irene vol. -
Treatment of Chronic Alcoholism: an Integrated Approach Hemangi Rajput* Integrative Health Care Practitioner, Essence Natural Health Clinic, Canada
Integrati & ve e M iv t e a d n i c r i e n t l e A Alternative & Integrative Medicine Rajput, Altern Integ Med 2014, 3:2 ISSN: 2327-5162 DOI: 10.4172/2327-5162.1000152 Review Article Open Access Treatment of Chronic Alcoholism: An Integrated Approach Hemangi Rajput* Integrative Health care Practitioner, Essence Natural Health Clinic, Canada Abstract Alternative medicine coupled with conventional and psychosocial therapies has been shown to be greatly effective in treating chronic alcoholism with positive treatment outcomes. Herbs like Kudzu, Tangerine Peel, Gentian and Bupleurum have been used efficaciously to treat chronic alcoholism and reduce liver toxicity. This article reviews the herbs Kudzu, Tangerine Peel, Gentian and Bupleurum with respect to their actions on the enzymes alcohol and acetaldehyde dehydrogenase. We further explore the genetic and pathophysiological basis of alcoholism while unraveling genetic polymorphisms in the genes involved in metabolic and effector action pathways that have an important bearing on why some individuals are addicted to alcohol, have severe withdrawal response and increased tendency to relapse. In this article we mainly discuss the role of alternative medicine, specifically in context with the above mentioned herbs for their role in inhibiting production of acetaldehyde dehydrogenase, suppressing craving, regulating blood glucose balance and reducing hepatotoxicity in chronic alcoholics. Keywords: Acetaldehyde dehydrogenase; Alternative medicine; Alternative treatment with herbs has shown to be effective in Bupleurum; Chronic alcoholism; Gentian; Integrated medicine; ameliorating the side-effects of withdrawal, restore optimal homeostasis Kudzu; Tangerine Peel and decrease psychological dependence in chronic alcoholics. Background Pathophysiology of Chronic Alcoholism Alcoholism has been described as early as 1700 BC in “The book To treat alcoholism, we need to understand how ethanol is of Anni” where Egyptians described excessive intoxication in humans. -
Human Pluripotent Stem Cell-Derived Ectomesenchymal Stromal Cells Promote More Robust Functional Recovery Than Umbilical Cord-De
Human pluripotent stem cell-derived ectomesenchymal stromal cells promote more robust functional recovery than umbilical cord-derived mesenchymal stromal cells after hypoxic- ischaemic brain damage Jiawei Huang1,3*, Kin Pong U1,3*, Fuyuan Yang1, Zeyuan Ji1, Jiacheng Lin1,3, Zhihui Weng1, Lai Ling Tsang1,3, Tobias D Merson5, Ye Chun Ruan6, Chao Wan1,3, Gang Li2, Xiaohua Jiang1,3,4 1School of Biomedical Sciences, 2Department of Orthopaedics and Traumatology, Faculty of Medicine, The Chinese University of Hong Kong, Hong Kong SAR, PR China. 3School of Biomedical Sciences Core Laboratory, Shenzhen Research Institute, The Chinese University of Hong Kong, Shenzhen, PR China. 4Sichuan University – The Chinese University of Hong Kong Joint Laboratory for Reproductive Medicine, West China Second University Hospital, Sichuan University, Chengdu 610041, Sichuan, China. 5Australian Regenerative Medicine Institute, Monash University, Clayton, VIC, Australia. 6Department of Biomedical Engineering, Faculty of Engineering, The Hong Kong Polytechnic University, Hong Kong, China. Running Title: Human ectomesenchymal stromal cells promote functional recovery in a rat HIE model *Corresponding author: Prof. Xiaohua JIANG, Email: [email protected] Address: Room 409A, Lo Kwee Seong Integrated Biomedical Sciences Building, Area 39, The Chinese University of Hong Kong, Shatin. Keywords: HIE, ectomesenchymal stromal cells, brain damage, regeneration, paracrine, ERK Abstract: Aims: Hypoxic-ischaemic encephalopathy (HIE) is one of the most serious complications in neonates and infants. Mesenchymal stromal cell (MSC)-based therapy is emerging as a promising treatment avenue for HIE. However, despite its enormous potential, the clinical application of MSCs is limited by cell heterogeneity, low isolation efficiency and unpredictable effectiveness. In this study, we examined the therapeutic effects and underlying mechanisms of human pluripotent stem cell-derived ectomesenchymal stromal cells (hPSC-EMSCs) in a rat model of HIE. -
Prostaglandin E2 As Mediator and Modulator of Airway Smooth Muscle Responses
Institute of Environmental Medicine Division of Physiology The Unit for Experimental Asthma and Allergy Research Karolinska Institutet, Stockholm, Sweden PROSTAGLANDIN E2 AS MEDIATOR AND MODULATOR OF AIRWAY SMOOTH MUSCLE RESPONSES Jesper Säfholm Stockholm 2013 All published papers were reproduced with permission from the publisher. Published by Karolinska Institutet. Printed by Repro Print AB © Jesper Säfholm, 2013 ISBN 978-91-7549-167-7 Printed by 2013 Gårdsvägen 4, 169 70 Solna To boldly go where a lot of people have gone before ABSTRACT Prostaglandin E2 (PGE2) is a lipid mediator produced by virtually every cell of the human body. Because common non-steroidal anti-inflammatory drugs (NSAIDs) inhibit its biosynthesis, PGE2 is usually considered to be a ‘pro-inflammatory’ mediator. The role of PGE2 in the lung and airways has however always been unclear. In particular, the airway responses caused by activation of its four different EP receptors have been debated. Research on the mechanisms involved in the actions of PGE2 has previously been limited by the low potency and selectivity of available pharmacological tools. Recently, a number of potent receptor antagonists and enzyme inhibitors have become available. The aim of this thesis was therefore to characterise airway responses to PGE2 in greater detail, focusing on the role of its receptors on baseline smooth muscle function and during antigen-induced contractions. Alongside investigating PGE2 responses, the newly discovered relaxant effects of bitter tasting substances acting at their respective receptors (TAS2Rs) were examined. The project mainly involved analysis of isometric contractions and relaxations in isolated airways from guinea pigs and humans in organ baths.